HOME >> BIOLOGY >> NEWS
Alliance for Cancer Gene Therapy announces $1.5 million in national grants to young investigators

Margaret Cianci, Executive Director for the Alliance for Cancer Gene Therapy, Inc. (ACGT), a national foundation based in Stamford, Connecticut, announced today the award of national grants to three Young Investigators at major research institutions, totaling $1.5 million over three years, for separate cancer gene therapy research projects relating to neuroblastoma, prostate and ovarian cancers.

The recipients are Dr. Andrew Davidoff at St. Jude Children's Research Hospital, Memphis, Tennessee for the development of anti-angiogenic gene therapy for neuroblastoma, a deadly form of childhood cancer; Dr. Thomas Griffith at the University of Iowa for development and testing of an immunotherapy/vaccine therapy, Ad-5 TRAIL for future clinical trials in patients with prostate cancer; and Dr. Jeffrey Bartlett, at Children's Research Institute in Columbus, Ohio, for tumor targeting/vector development, creating a specific gene therapy delivery vehicle for patients with ovarian cancer.

Gene therapy is a revolutionary new form of treatment. It has emerged in recent years with the remarkable potential not only to deliver a cure for many types of cancers, but also to improve the quality of life with reduced side effects for patients undergoing treatments.

Every year, over a half million people die from cancer and another million are diagnosed with some form of the disease. Conventional therapies, including chemotherapy, surgery, and radiation, while having produced a measure of success with some cancers, have their limitations and can generate adverse side effects for patients.

The research efforts of these Young Investigators, pursuing newly emerging strategies within the cancer gene therapy field, represent significant potential applications for all forms of cancer and an improved quality of life for those being treated for cancer.

1.Anti-Angiogenesis:
Andrew Davidoff, M.D.
St. Jude Children's Research H
'"/>

Contact: Margaret Cianci
info@acgtfoundation.org
203-358-8000
Alliance for Cancer Gene Therapy
3-Mar-2003


Page: 1 2 3 4

Related biology news :

1. USAID, Conservation International & Starbucks launch Conservation Coffee Alliance in Central America
2. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
3. AACR and The V Foundation form Translational Cancer Research Alliance
4. Ecology lab aids Turtle Survival Alliance
5. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
6. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
7. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
8. Cancer gene MYC emerging as key research target
9. Cancer patient, heal thyself
10. USC researcher named General Motors Cancer Research Scholar
11. Fox Chase Cancer Centers Alfred Knudson Jr. named 2004 Kyoto Prize winner

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/8/2019)... ... , ... PureWay, a healthcare-focused provider of sharps disposal, biohazard ... of sales and business development efforts, effective immediately. Mr. Kennedy will report directly ... Johnson & Johnson Medical, Globus Medical, WRP Asia Pacific, and Stryker, all where ...
(Date:1/7/2019)... ... January 07, 2019 , ... Concerto HealthAI, a ... precision health in oncology and other key therapeutic areas, and its Chief Executive ... entrepreneurs and executives spanning the entire healthcare landscape, on January 8, 2019, at ...
(Date:1/5/2019)... ... 04, 2019 , ... Join Bill Fox, Chief Strategy Officer, ... from MarkLogic – for a live webinar on Wednesday, January 16, ... using real world data for pharmacovigilance, and the implications of current inefficient data ...
Breaking Biology News(10 mins):
(Date:1/11/2019)... , ... January 11, 2019 , ... Drawing on over ... Tuesday, January 22, 2019 at 2:30pm EST will explore some of the key lessons ... of using one vendor vs. using multiple vendors, and find out how to ensure ...
(Date:1/8/2019)... ... January 07, 2019 , ... ... into Noninvasix. This represents the second investment AngelMD has made into Noninvasix in ... Noninvasix is developing a patient monitor to directly, accurately, and noninvasively measure brain ...
(Date:1/4/2019)... , ... January 01, 2019 , ... ... Microbiome Conference at the World Economic Forum Annual Meeting January 22-25, 2019 held ... is invitation-only. , The World Economic Forum Annual Meeting brings together leaders of ...
(Date:12/19/2018)... ... December 19, 2018 , ... R3 Stem Cell is ... Training Course in Las Vegas. Training includes facial rejuvenation, hair restoration and erectile ... nationwide for aesthetics, having the training from expert, Board Certified providers is critical ...
Breaking Biology Technology:
Cached News: